Caitong International Asset Management Co., Ltd
Position in FULC — Fulcrum Therapeutics, Inc.
CIK 1963355
HONG KONG, K3
Position in FULC
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$29,012
+$27,003 QoQ
Shares Held
7,927
+2925.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#118
of 154 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caitong International Asset Management Co., Ltd holds $9,932,177 across 352 Biotechnology names. FULC ranks #49 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABSI |
Absci Corp
|
157,319 | $1,823,327 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
46,732 | $790,705 | |
| 3 | TECH |
BIO-TECHNE Corp
|
9,888 | $698,587 | |
| 4 | ARGX |
Argenx SE
|
655 | $607,689 | |
| 5 | QURE |
uniQure N.V.
|
9,644 | $444,202 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
10,377 | $356,138 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,682 | $328,122 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
41,632 | $326,811 |
All Filings in FULC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,012 | 7,927 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,009 | 262 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $463 | 41 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $4,340 | 1,507 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||